- Home
- MSI vs CANF Comparison
MSI vs CANF Comparison
Compare MSI & CANF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MSI | CANF |
|---|---|---|
| Founded | 1928 | 1994 |
| Country | United States | Israel |
| Employees | N/A | 5 |
| Industry | Radio And Television Broadcasting And Communications Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 76.5B | 4.7M |
| IPO Year | 1994 | 2011 |
Fundamental Metrics
Financial Performance| Metric | MSI | CANF |
|---|---|---|
| Price | $473.36 | $3.60 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 2 |
| Target Price | $501.57 | ★ $9,750.00 |
| AVG Volume (30 Days) | ★ 1.0M | 634.9K |
| Earning Date | 05-13-2026 | 01-01-0001 |
| Dividend Yield | ★ 1.05% | N/A |
| EPS Growth | ★ 38.14 | N/A |
| EPS | ★ 12.75 | N/A |
| Revenue | ★ $6,380,000,000.00 | N/A |
| Revenue This Year | $9.78 | $461.72 |
| Revenue Next Year | $5.93 | $290,391.28 |
| P/E Ratio | $36.40 | ★ N/A |
| Revenue Growth | ★ 5.66 | N/A |
| 52 Week Low | $359.36 | $0.17 |
| 52 Week High | $490.24 | $10.40 |
Technical Indicators
Market Signals| Indicator | MSI | CANF |
|---|---|---|
| Relative Strength Index (RSI) | 65.02 | 40.57 |
| Support Level | $449.65 | $0.60 |
| Resistance Level | $487.90 | $4.74 |
| Average True Range (ATR) | 8.42 | 0.71 |
| MACD | -3.08 | -0.19 |
| Stochastic Oscillator | 53.93 | 1.16 |
Price Performance
Historical ComparisonAbout MSI Motorola Solutions Inc.
Motorola Solutions is a leading provider of communications and analytics, primarily serving public safety departments as well as schools, hospitals, and businesses. The bulk of the firm's revenue comes from sales of land mobile radios and radio network infrastructure, but the firm also sells surveillance equipment, dispatch software, and other networking capabilities. Most of Motorola's revenue comes from government agencies, while roughly 25% comes from schools and private businesses. Motorola has customers in over 100 countries and in every state in the United States.
About CANF Can-Fite Biopharma Ltd Sponsored ADR (Israel)
Can Fite Biopharma Ltd is a clinical-stage biopharmaceutical company. The company focuses on developing orally bioavailable small-molecule drugs targeting the A3 adenosine receptor for treating cancer, inflammatory diseases, liver disorders, and related conditions. It has a pipeline of proprietary drug candidates in Phase II and Phase III clinical development. The company's platform targets the A3 adenosine receptor (A3AR), which is more expressed in inflammatory and cancerous cells than in normal cells. Its pipeline drugs include Namodenoson, Piclidenoson, CF602, and Cannabinoids.